All In MedTech

Device Trial Radar · NCT07912892

Treating PHPT With the nPulse™ Vybrance™ PE System

Clinical Evaluation of the nPulse™ VYBRANCE™ Percutaneous Electrode System in Treating Primary Hyperparathyroidism

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Nov 30, 2026

Primary completion

Nov 30, 2027

Study completion Jun 30, 2028

Sponsor

Lead sponsor
Pulse Biosciences, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to treat patients with the nPulse system and evaluate their outcomes following treatment. The study seeks to characterize patient outcomes and assess changes in serum calcium, ionized calcium, and parathyroid hormone (PTH) levels after treatment with nPulse.

Conditions

  • Primary Hyperparathyroidism

Interventions

  • Ultrasound-Guided Parathyroid Nanosecond Pulsed Field Ablation (nsPFA)Device

    Participants will undergo ultrasound-guided, non-surgical, non-thermal nanosecond pulse field ablation (nsPFA) of the targeted parathyroid gland using the nPulse™ system.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Primary Safety Events (PSEs)Time frame: From procedure through 6 months post-procedure
  2. Normalization of corrected serum calcium and ionized calcium levelsTime frame: 6 months post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sarasota Memorial Health Care System

    Sarasota, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.